Circulating endothelial cells in coronary artery disease and acute coronary syndrome

Trends in Cardiovascular Medicine

Volumn 25, Issue 7, 2015, Pages 578-587

  Schmidt, David E ^a   Manca, Marco ^b,c   Hoefer, Imo E ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD146 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 6; THROMBOMODULIN; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR; BIOLOGICAL MARKER;

ACUTE CORONARY SYNDROME; APOPTOSIS; BLOOD VESSEL INJURY; CELL DIFFERENTIATION; CELL MIGRATION; CELL STRUCTURE; CIRCULATING ENDOTHELIAL CELL; CONSENSUS; CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL MICROPARTICLE; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; HEMOSTASIS; HUMAN; NEOVASCULARIZATION (PATHOLOGY); NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; NONHUMAN; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSTIC ASSESSMENT; PROTEOMICS; REVIEW; SCREENING; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBOSIS; TRANSCRIPTOMICS; UNSTABLE ANGINA PECTORIS; ANIMAL; BLOOD; MEMBRANE MICROPARTICLE; METABOLISM; PATHOLOGY; PROGNOSIS;

ACUTE CORONARY SYNDROME; ANIMALS; BIOMARKERS; CELL-DERIVED MICROPARTICLES; CORONARY ARTERY DISEASE; ENDOTHELIAL CELLS; ENDOTHELIAL PROGENITOR CELLS; HUMANS; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 84941995767     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2015.01.013     Document Type: Review

References (81)

1. Lozano R., Naghavi M., Foreman K., Lim S., Shibuya K., Aboyans V., et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet 2012, 380:2095-2128.
2. Futterman L.G., Lemberg L. Fifty percent of patients with coronary artery disease do not have any of the conventional risk factors. Am J Crit Care. 1998, 7:240-244.
3. Dignat-George F., Sampol J. Circulating endothelial cells in vascular disorders: new insights into an old concept. Eur J Haematol 2000, 65:215-220.
4. Blann A.D., Woywodt A., Bertolini F., Bull T.M., Buyon J.P., Clancy R.M., et al. Circulating endothelial cells. Biomarker of vascular disease. Thromb Haemost 2005, 93:228-235.
5. Boos C.J., Lip G.Y.H., Blann A.D. Circulating endothelial cells in cardiovascular disease. J Am Coll Cardiol 2006, 48:1538-1547.
6. Sabatier F., Camoin-Jau L., Anfosso F., Sampol J., Dignat-George F. Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence. J Cell Mol Med 2009, 13:454-471.
7. Richardson M.R., Yoder M.C. Endothelial progenitor cells: quo vadis?. J Mol Cell Cardiol 2011, 50:266-272.
8. Donahue M., Quintavalle C., Chiariello G.A., Condorelli G., Briguori C. Endothelial progenitor cells in coronary artery disease. Biol Chem 2013, 394:1241-1252.
9. Lin Y., Weisdorf D.J., Solovey A., Hebbel R.P. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000, 105:71-77.
10. Boos C.J., Balakrishnan B., Jessani S., Blann A.D. Lip GYH. Effects of percutaneous coronary intervention on peripheral venous blood circulating endothelial cells and plasma indices of endothelial damage/dysfunction. Chest 2007, 132:1920-1926.
11. Deanfield J.E., Halcox J.P., Rabelink T.J. Endothelial function and dysfunction: testing and clinical relevance. Circulation 2007, 115:1285-1295.
12. Rüegg C., Yilmaz A., Bieler G., Bamat J., Chaubert P., Lejeune F.J. Evidence for the involvement of endothelial cell integrin alphaVbeta3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma. Nat Med 1998, 4:408-414.
13. Woywodt A. Circulating endothelial cells: life, death, detachment and repair of the endothelial cell layer. Nephrol Dial Transplant 2002, 17:1728-1730.
14. Bombeli T., Müller M., Straub P.W., Haeberli A. Cyclosporine-induced detachment of vascular endothelial cells initiates the intrinsic coagulation system in plasma and whole blood. J Lab Clin Med 1996, 127:621-634.
15. Swerlick R.A., Lee K.H., Wick T.M., Lawley T.J. Human dermal microvascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitro. J Immunol 1992, 148:78-83.
16. Chong A.Y., Lip G.Y.H., Freestone B., Blann A.D. Increased circulating endothelial cells in acute heart failure: comparison with von Willebrand factor and soluble E-selectin. Eur J Heart Fail 2006, 8:167-172.
17. Mutin M., Canavy I., Blann A., Bory M., Sampol J., Dignat-George F. Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells. Blood 1999, 93:2951-2958.
18. Petzelbauer P., Bender J.R., Wilson J., Pober J.S. Heterogeneity of dermal microvascular endothelial cell antigen expression and cytokine responsiveness in situ and in cell culture. J Immunol 1993, 151:5062-5072.
19. Freyssinet J.-M., Toti F. Formation of procoagulant microparticles and properties. Thromb Res 2010, 125:S46-S48.
20. Mallat Z., Benamer H., Hugel B., Benessiano J., Steg P.G., Freyssinet J.M., et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000, 101:841-843.
21. Solh El A.A., Akinnusi M.E., Berim I.G., Peter A.M., Paasch L.L., Szarpa K.R. Hemostatic implications of endothelial cell apoptosis in obstructive sleep apnea. Sleep Breath 2008, 12:331-337.
22. Bombeli T., Karsan A., Tait J.F., Harlan J.M. Apoptotic vascular endothelial cells become procoagulant. Blood 1997, 89:2429-2442.
23. Berckmans R.J., Nieuwland R., Böing A.N., Romijn F.P., Hack C.E., Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001, 85:639-646.
24. Makin A.J., Blann A.D., Chung N.A.Y., Silverman S.H. Lip GYH. Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor. Eur Heart J 2004, 25:371-376.
25. Freestone B., Lip G.Y.H., Chong A.Y., Nadar S., Lee K.W., Blann A.D. Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease. Thromb Haemost 2005.
26. Boos C.J., Balakrishnan B., Blann A.D. Lip GYH. The relationship of circulating endothelial cells to plasma indices of endothelial damage/dysfunction and apoptosis in acute coronary syndromes: implications for prognosis. J Thromb Haemost 2008, 6:1841-1850.
27. Boos C.J., Jaumdally R.J., MacFadyen R.J., Varma C. Lip GYH. Circulating endothelial cells and von Willebrand factor as indices of endothelial damage/dysfunction in coronary artery disease: a comparison of central vs. peripheral levels and effects of coronary angioplasty. J Thromb Haemost 2007, 5:630-632.
28. Boos C.J., Balakrishnan B., Lip G.Y.H. The effects of exercise stress testing on soluble E-selectin, von Willebrand factor, and circulating endothelial cells as indices of endothelial damage/dysfunction. Ann Med 2008, 40:66-73.
29. Lee K.W., Lip G.Y.H., Tayebjee M., Foster W., Blann A.D. Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes. Blood 2005, 105:526-532.
30. Martínez-Sales V., Sánchez-Lázaro I., Vila V., Almenar L., Contreras T., Reganon E. Circulating endothelial cells in patients with heart failure and left ventricular dysfunction. Dis Markers 2011, 31:75-82.
31. Nadar S.K., Lip G.Y.H., Lee K.W., Blann A.D. Circulating endothelial cells in acute ischaemic stroke. Thromb Haemost. 2005, 94:707-712.
32. Lee K.W., Blann A.D., Lip G.Y.H. Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes. Int J Cardiol 2006, 111:302-308.
33. Chong A.Y., Blann A.D., Patel J., Freestone B., Hughes E., Lip G.Y.H. Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide. Circulation 2004, 110:1794-1798.
34. Gao Y., Liu C., Zhang X., Gao J., Yang C. Circulating endothelial cells as potential markers of atherosclerosis. Can J Neurol Sci 2008, 35:638-642.
35. Onat D., Brillon D., Colombo P.C., Schmidt A.M. Human vascular endothelial cells: a model system for studying vascular inflammation in diabetes and atherosclerosis. Curr Diab Rep 2011, 11:193-202.
36. Fadini G.P., Avogaro A. Cell-based methods for ex vivo evaluation of human endothelial biology. Cardiovasc Res 2010, 87:12-21.
37. Solovey A., Gui L., Key N.S., Hebbel R.P. Tissue factor expression by endothelial cells in sickle cell anemia. J Clin Invest 1998, 101:1899-1904.
38. Mutunga M., Fulton B., Bullock R., Batchelor A., Gascoigne A., Gillespie J.I., et al. Circulating endothelial cells in patients with septic shock. Am J Respir Crit Care Med 2001, 163:195-200.
39. Campioni D., Zauli G., Gambetti S., Campo G., Cuneo A., Ferrari R., et al. In vitro characterization of circulating endothelial progenitor cells isolated from patients with acute coronary syndrome. PLoS One 2013, 8:e56377.
40. Lee D.Y., Cho T.-J., Kim J.A., Lee H.R., Yoo W.J., Chung C.Y., et al. Mobilization of endothelial progenitor cells in fracture healing and distraction osteogenesis. Bone 2008, 42:932-941.
41. Heissig B., Hattori K., Dias S., Friedrich M., Ferris B., Hackett N.R., et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002, 109:625-637.
42. Teraa M., Sprengers R.W., Westerweel P.E., Gremmels H., Goumans M.-J.T.H., Teerlink T., et al. Bone marrow alterations and lower endothelial progenitor cell numbers in critical limb ischemia patients. PLoS One 2013, 8:e55592.
43. Yip H.-K., Sun C.-K., Tsai T.-H., Sheu J.-J., Kao Y.-H., Lin Y.-C., et al. Tissue plasminogen activator enhances mobilization of endothelial progenitor cells and angiogenesis in murine limb ischemia. Int J Cardiol. 2013, 168:226-236.
44. Bertolini F., Shaked Y., Mancuso P., Kerbel R.S. The multifaceted circulating endothelial cell in cancer: toward marker and target identification. Nat Rev Cancer 2006, 6:835-845.
45. George A.L., Bangalore-Prakash P., Rajoria S., Suriano R., Shanmugam A., Mittelman A., et al. Endothelial progenitor cell biology in disease and tissue regeneration. J Hematol Oncol 2011, 4:24.
46. Rafii S. Circulating endothelial precursors: mystery, reality, and promise. J Clin Invest 2000, 105:17-19.
47. Werner N., Kosiol S., Schiegl T., Ahlers P., Walenta K., Link A., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005, 353:999-1007.
48. Hill J.M., Zalos G., Halcox J.P.J., Schenke W.H., Waclawiw M.A., Quyyumi A.A., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003, 348:593-600.
49. Bonello L., BASIRE A., Sabatier F., Paganelli F., Dignat-George F. Endothelial injury induced by coronary angioplasty triggers mobilization of endothelial progenitor cells in patients with stable coronary artery disease1. J Thromb Haemost 2006, 4:979-981.
50. Woywodt A., Erdbruegger U., Haubitz M. Circulating endothelial cells and endothelial progenitor cells after angioplasty: news from the endothelial rescue squad. J Thromb Haemost 2006, 4:976-978.
51. Nomura S., Ozaki Y., Ikeda Y. Function and role of microparticles in various clinical settings. Thromb Res 2008, 123:8-23.
52. Burger D., Touyz R.M. Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells, and circulating endothelial cells. J Am Soc Hypertens 2012, 6:85-99.
53. Lanuti P., Santilli F., Marchisio M., Pierdomenico L., Vitacolonna E., Santavenere E., et al. A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: relevance for the evaluation of endothelial dysfunction. J Immunol Methods. 2012, 380:16-22.
54. Lee S.-T., Chu K., Jung K.-H., Kim J.-M., Moon H.-J., Bahn J.-J., et al. Circulating CD62E+ microparticles and cardiovascular outcomes. PLoS One 2012, 7:e35713.
55. Sinning J.-M., Losch J., Walenta K., Böhm M., Nickenig G., Werner N. Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes. Eur Heart J 2011, 32:2034-2041.
56. Bernal-Mizrachi L., Jy W., Jimenez J.J., Pastor J., Mauro L.M., Horstman L.L., et al. High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J 2003, 145:962-970.
57. Zielińska M., Koniarek W., Goch J.H., Cebula B., Tybura M., Robak T., et al. Circulating endothelial microparticles in patients with acute myocardial infarction. Kardiol Pol 2005, 62:531-542. [discussion 543-4].
58. Jung C., Sörensson P., Saleh N., Arheden H., Rydén L., Pernow J. Circulating endothelial and platelet derived microparticles reflect the size of myocardium at risk in patients with ST-elevation myocardial infarction. Atherosclerosis 2012, 221:226-231.
59. Théry C., Ostrowski M., Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009, 9:581-593.
60. Montoro-García S., Shantsila E., Marín F., Blann A. Lip GYH. Circulating microparticles: new insights into the biochemical basis of microparticle release and activity. Basic Res Cardiol 2011, 106:911-923.
61. Collier M.E.W., Mah P.-M., Xiao Y., Maraveyas A., Ettelaie C. Microparticle-associated tissue factor is recycled by endothelial cells resulting in enhanced surface tissue factor activity. Thromb Haemost 2013, 110:966-976.
62. Boos C.J., Lane D.A., Karpha M., Beevers D.G., Haynes R. Lip GYH. Circulating endothelial cells, arterial stiffness, and cardiovascular risk stratification in hypertension. Chest 2007, 132:1540-1547.
63. Boos C.J., Soor S.K., Kang D., Lip G.Y.H. Relationship between circulating endothelial cells and the predicted risk of cardiovascular events in acute coronary syndromes. Eur Heart J 2007, 28:1092-1101.
64. Mourino-Alvarez L., Calvo E., Moreu J., Padial L.R., Lopez J.A., Barderas M.G., et al. Proteomic characterization of EPCs and CECs "in vivo" from acute coronary syndrome patients and control subjects. Biochim Biophys Acta. 2013, 1830:3030-3053.
65. Boos C.J., Lane D.A., Kang D., Goon P.K.Y., Blann A.D. Lip GYH. Temporal and venepuncture-related decline in circulating endothelial cell capture from mixed venous blood. J Thromb Thrombolysis 2006, 22:125-131.
66. Li C., Wu Q., Liu B., Yao Y., Chen Y., Zhang H., et al. Detection and validation of circulating endothelial cells, a blood-based diagnostic marker of acute myocardial infarction. PLoS One 2013, 8:e58478.
67. Quilici J., Banzet N., Paule P., Meynard J.-B., Mutin M., Bonnet J.-L., et al. Circulating endothelial cell count as a diagnostic marker for non-ST-elevation acute coronary syndromes. Circulation 2004, 110:1586-1591.
68. Leask R.L., Jain N., Butany J. Endothelium and valvular diseases of the heart. Microsc Res Tech 2003, 60:129-137.
69. Damani S., Bacconi A., Libiger O., Chourasia A.H., Serry R., Gollapudi R., et al. Characterization of circulating endothelial cells in acute myocardial infarction. Sci Transl Med 2012, 4. 126ra33-3.
70. Bethel K., Luttgen M.S., Damani S., Kolatkar A., Lamy R., Sabouri-Ghomi M., et al. Fluid phase biopsy for detection and characterization of circulating endothelial cells in myocardial infarction. Phys Biol 2014, 11:016002.
71. Mancuso P., Burlini A., Pruneri G., Goldhirsch A., Martinelli G., Bertolini F. Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood 2001, 97:3658-3661.
72. Kraan J., Sleijfer S., Foekens J.A., Gratama J.W. Clinical value of circulating endothelial cell detection in oncology. Drug Discov Today. 2012, 17:710-717.
73. Blann A.D., Pretorius A. Circulating endothelial cells and endothelial progenitor cells: two sides of the same coin, or two different coins?. Atherosclerosis 2006, 188:12-18.
74. Rusk A., McKeegan E., Haviv F., Majest S., Henkin J., Khanna C. Preclinical evaluation of antiangiogenic thrombospondin-1 peptide mimetics, ABT-526 and ABT-510, in companion dogs with naturally occurring cancers. Clin Cancer Res 2006, 12:7444-7455.
75. Monestiroli S., Mancuso P., Burlini A., Pruneri G., Dell'Agnola C., Gobbi A., et al. Kinetics and viability of circulating endothelial cells as surrogate angiogenesis marker in an animal model of human lymphoma. Cancer Res 2001, 61:4341-4344.
76. Tropea M.M., Harper B.J.A., Graninger G.M., Phillips T.M., Ferreyra G., Mostowski H.S., et al. Isolation of a circulating CD45-, CD34dim cell population and validation of their endothelial phenotype. Thromb Haemost 2014, 112:770-780.
77. Dignat-George F., Brisson C., Poncelet P., Laurent J.C., Massot O., Arnoux D., et al. Rapid isolation of human endothelial cells from whole blood using S-Endo1 monoclonal antibody coupled to immuno-magnetic beads: demonstration of endothelial injury after angioplasty. Thromb Haemost 1992, 67:147-153.
78. Hladovec J., Přerovský I., Staněk V., Fabián J. Endotheliale Zellen im zirkulierenden Blut bei akutem Myokardinfarkt und Angina pectoris. Klin Wochenschr 1978, 56:1033-1036.
79. Lampka M., Grabczewska Z., Jendryczka-Maćkiewicz E., Hołyńska-Iwan I., Sukiennik A., Kubica J., et al. Circulating endothelial cells in coronary artery disease. Kardiol Pol 2010, 68:1100-1105.
80. Vargová K., Toth-Zsamboki E., Beres B.J., Bencze J., Kerecsen G., Gulacsi-Bardos P., et al. Circulating endothelial cell count, plasma vWF and soluble ICAM-1 levels following primary or elective percutaneous coronary intervention. Atherosclerosis 2008, 198:366-372.
81. Wang C., Li H., Fu P., Zhang S., Xiu R. Serum C-reactive protein and circulating endothelial cells in patients with acute myocardial infarction. Clin Hemorheol Microcirc 2005, 32:287-296.